Print  |  Font Size Change Font Size
Search naabt.org  

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Help your website visitors find a certified physician, counselor
or request a resource kit by adding a banner to your website

This convenient shortcut banner can easily be added to your existing website. It provides a simple way for your visitors to find buprenorphine treatment resources without the need to navigate through our entire site. Choose from the banners below for the one that best fits your website design. We would appreciate it very much if you would email us once the banner is on your site, or to report any problems. Thank you! banners@naabt.org

NOTE: If you would like to add our banners to Social networking sites (i.e. MySpace, Facebook, etc.) please use the code provided on this page instead.

Webmasters: If you hate Flash, we have alternative for you, Javascript (or you could use the versions we provide for MySpace users but we prefer you use the Flash or Javascript versions).

180 x 150


468 x 60


120 x 90


93 x 70


119 x 45


180 x 150


468 x 60


120 x 90


93 x 70


119 x 45


180 x 150


468 x 60


120 x 90


93 x 70


119 x 45


180 x 150


468 x 60


120 x 90


93 x 70


119 x 45


This page was last modified on : 10/06/2009
National Drug & Alcohol Recovery MonthAddiction Survivors National Institute of HealthAlcohol AnswersNIDA
  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.